FDA Drug Recalls

6,161 recalls · Class II, newest first

Jul 17, 2023 Class II · Moderate risk

PHENYLephrine in 0.9 sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-6008-1 D-1077-2023

Jul 17, 2023 Class II · Moderate risk

rocuronium

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-1076-2023

Jul 17, 2023 Class II · Moderate risk

midazolam in dextrose 5%

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-4036-1 D-1075-2023

Jul 17, 2023 Class II · Moderate risk

lidocaine 2%

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-1074-2023

Jul 17, 2023 Class II · Moderate risk

ePHEDrine in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-6004-1 D-1073-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium…

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2082-2 D-1072-2023

Jul 17, 2023 Class II · Moderate risk

ketamine in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-3022-1 D-1071-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2082-1 D-1070-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2081-1 D-1069-2023

Jul 17, 2023 Class II · Moderate risk

morphine in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2041-2 D-1068-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2080-2 D-1067-2023

Jul 17, 2023 Class II · Moderate risk

PHENYLephrine in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-6009-1 D-1066-2023

Jul 17, 2023 Class II · Moderate risk

morphine in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2040-3 D-1065-2023

Jul 17, 2023 Class II · Moderate risk

morphine in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2040-1 D-1064-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2074-1 D-1063-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2071-7 D-1062-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2071-5 D-1061-2023

Jul 17, 2023 Class II · Moderate risk

HYDROmorphone in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2012-1 D-1060-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2071-4 D-1059-2023

Jul 17, 2023 Class II · Moderate risk

HYDROmorphone in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2011-1 D-1058-2023

Jul 17, 2023 Class II · Moderate risk

HYDROmorphone in Dextrose 5%

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2013-1 D-1057-2023

Jul 17, 2023 Class II · Moderate risk

succinylcholine

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-6011-2 D-1056-2023

Jul 17, 2023 Class II · Moderate risk

HYDROmorphone in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2010-2 D-1055-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-2071-3 D-1054-2023

Jul 17, 2023 Class II · Moderate risk

fentaNYL in 0.9% sodium chloride

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-1053-2023

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061